Raras
Buscar doenças, sintomas, genes...
Encefalite por vírus herpes simplex
ORPHA:1930CID-10 · B00.4+CID-11 · 1F00.21DOENÇA RARA

A Encefalite por Herpes Simples (EHS) é uma inflamação grave do cérebro causada pelo vírus do Herpes Simples (HSV), que pode ter um desenvolvimento muito sério e ser fatal, principalmente se o tratamento for atrasado ou não for feito. O vírus do Herpes Simples (HSV) geralmente afeta as partes da frente e das laterais do cérebro, normalmente de forma desigual (um lado mais que o outro). Isso pode causar mudanças de personalidade, problemas de memória e raciocínio, dificuldade para falar ou entender o que os outros dizem, convulsões e fraqueza em alguma parte específica do corpo.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A Encefalite por Herpes Simples (EHS) é uma inflamação grave do cérebro causada pelo vírus do Herpes Simples (HSV), que pode ter um desenvolvimento muito sério e ser fatal, principalmente se o tratamento for atrasado ou não for feito. O vírus do Herpes Simples (HSV) geralmente afeta as partes da frente e das laterais do cérebro, normalmente de forma desigual (um lado mais que o outro). Isso pode causar mudanças de personalidade, problemas de memória e raciocínio, dificuldade para falar ou entender o que os outros dizem, convulsões e fraqueza em alguma parte específica do corpo.

Publicações científicas
568 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: B00.4+
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
6 sintomas
🩸
Sangue
3 sintomas
🫁
Pulmão
1 sintomas
🛡️
Imunológico
1 sintomas
🫃
Digestivo
1 sintomas
📏
Crescimento
1 sintomas

+ 17 sintomas em outras categorias

Características mais comuns

90%prev.
Anormalidade no EEG
Muito frequente (99-80%)
90%prev.
Consciência/confusão reduzida
Muito frequente (99-80%)
90%prev.
Morfologia anormal do cérebro
Muito frequente (99-80%)
90%prev.
Pleocitose linfocitária do LCR
Muito frequente (99-80%)
55%prev.
Fadiga
Frequente (79-30%)
55%prev.
Convulsão
Frequente (79-30%)
30sintomas
Muito frequente (4)
Frequente (13)
Ocasional (13)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 30 características clínicas mais associadas, ordenadas por frequência.

Anormalidade no EEGEEG abnormality
Muito frequente (99-80%)90%
Consciência/confusão reduzidaReduced consciousness/confusion
Muito frequente (99-80%)90%
Morfologia anormal do cérebroAbnormality of brain morphology
Muito frequente (99-80%)90%
Pleocitose linfocitária do LCRCSF lymphocytic pleiocytosis
Muito frequente (99-80%)90%
FadigaFatigue
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico568PubMed
Últimos 10 anos200publicações
Pico202324 papers
Linha do tempo
2026Hoje · 2026🧪 1997Primeiro ensaio clínico📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

5 genes identificados com associação a esta condição. Padrão de herança: Multigenic/multifactorial, Not applicable.

TICAM1TIR domain-containing adapter molecule 1Major susceptibility factor inDesconhecido
FUNÇÃO

Involved in innate immunity against invading pathogens. Adapter used by TLR3, TLR4 (through TICAM2) and TLR5 to mediate NF-kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis (PubMed:12471095, PubMed:12539043, PubMed:14739303, PubMed:28747347, PubMed:35215908). Ligand binding to these receptors results in TRIF recruitment through its TIR domain (PubMed:12471095, PubMed:12539043, PubMed:14739303). Distinct protein-interaction motifs allow recruitment of the effector

LOCALIZAÇÃO

Cytoplasmic vesicle, autophagosomeCytoplasm, cytosolMitochondrion

VIAS BIOLÓGICAS (8)
TICAM1,TRAF6-dependent induction of TAK1 complexToll Like Receptor 3 (TLR3) CascadeRIP-mediated NFkB activation via ZBP1TICAM1, RIP1-mediated IKK complex recruitmentTLR3-mediated TICAM1-dependent programmed cell death
MECANISMO DE DOENÇA

Encephalopathy, acute, infection-induced, 6, herpes-specific

A rare complication of human herpesvirus 1 (HHV-1) infection, occurring in only a small minority of HHV-1 infected individuals. It is characterized by hemorrhagic necrosis of parts of the temporal and frontal lobes. Onset is over several days and involves fever, headache, seizures, stupor, and often coma, frequently with a fatal outcome.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
60.9 TPM
Linfócitos
46.6 TPM
Aorta
34.9 TPM
Skin Not Sun Exposed Suprapubic
32.1 TPM
Pulmão
31.5 TPM
OUTRAS DOENÇAS (2)
herpes simplex encephalitisherpes simplex encephalitis, susceptibility to, 4
HGNC:18348UniProt:Q8IUC6
UNC93B1Protein unc-93 homolog B1Major susceptibility factor inTolerante
FUNÇÃO

Plays an important role in innate and adaptive immunity by regulating nucleotide-sensing Toll-like receptor (TLR) signaling. Required for the transport of a subset of TLRs (including TLR3, TLR7 and TLR9) from the endoplasmic reticulum to endolysosomes where they can engage pathogen nucleotides and activate signaling cascades. May play a role in autoreactive B-cells removal

LOCALIZAÇÃO

Endoplasmic reticulum membraneEndosomeLysosomeCytoplasmic vesicle, phagosome

VIAS BIOLÓGICAS (1)
Trafficking and processing of endosomal TLR
MECANISMO DE DOENÇA

Encephalopathy, acute, infection-induced, 1, herpes-specific

A rare complication of human herpesvirus 1 (HHV-1) infection, occurring in only a small minority of HHV-1 infected individuals. It is characterized by hemorrhagic necrosis of parts of the temporal and frontal lobes. Onset is over several days and involves fever, headache, seizures, stupor, and often coma, frequently with a fatal outcome.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
128.5 TPM
Linfócitos
76.4 TPM
Sangue
66.9 TPM
Pulmão
60.4 TPM
Intestino delgado
52.1 TPM
OUTRAS DOENÇAS (2)
herpes simplex encephalitisherpes simplex encephalitis, susceptibility to, 1
HGNC:13481UniProt:Q9H1C4
TBK1Serine/threonine-protein kinase TBK1Major susceptibility factor inAltamente restrito
FUNÇÃO

Serine/threonine kinase that plays an essential role in regulating inflammatory responses to foreign agents (PubMed:10581243, PubMed:11839743, PubMed:12692549, PubMed:12702806, PubMed:14703513, PubMed:15367631, PubMed:15485837, PubMed:18583960, PubMed:21138416, PubMed:23453971, PubMed:23453972, PubMed:23746807, PubMed:25636800, PubMed:26611359, PubMed:32404352, PubMed:34363755, PubMed:32298923). Following activation of toll-like receptors by viral or bacterial components, associates with TRAF3 a

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (10)
PINK1-PRKN Mediated MitophagyDDX58/IFIH1-mediated induction of interferon-alpha/betaSARS-CoV-2 activates/modulates innate and adaptive immune responsesTRAF3-dependent IRF activation pathwayTRAF6 mediated IRF7 activation
MECANISMO DE DOENÇA

Glaucoma 1, open angle, P

A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. GLC1P is characterized by early onset, thin central corneas and low intraocular pressure.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
50.3 TPM
Testículo
42.8 TPM
Fibroblastos
35.0 TPM
Pulmão
30.8 TPM
Útero
30.3 TPM
OUTRAS DOENÇAS (6)
autoinflammation with arthritis and vasculitisfrontotemporal dementia and/or amyotrophic lateral sclerosis 4amyotrophic lateral sclerosisfrontotemporal dementia with motor neuron disease
HGNC:11584UniProt:Q9UHD2
TLR3Toll-like receptor 3Major susceptibility factor inTolerante
FUNÇÃO

Key component of innate and adaptive immunity. TLRs (Toll-like receptors) control host immune response against pathogens through recognition of molecular patterns specific to microorganisms. TLR3 is a nucleotide-sensing TLR which is activated by double-stranded RNA, a sign of viral infection. Acts via the adapter TRIF/TICAM1, leading to NF-kappa-B activation, IRF3 nuclear translocation, cytokine secretion and the inflammatory response

LOCALIZAÇÃO

Endoplasmic reticulum membraneEndosome membraneEarly endosome

VIAS BIOLÓGICAS (10)
TICAM1,TRAF6-dependent induction of TAK1 complexToll Like Receptor 3 (TLR3) CascadeRIP-mediated NFkB activation via ZBP1TICAM1, RIP1-mediated IKK complex recruitmentTLR3-mediated TICAM1-dependent programmed cell death
MECANISMO DE DOENÇA

Immunodeficiency 83, susceptibility to viral infections

An immunologic disorder characterized by increased susceptibility to severe viral infections, including herpes simplex virus (HSV), varicella zoster virus (VZV), influenza A virus (IAV), hantavirus, and possibly respiratory syncytial virus (RSV). IMD83 clinical manifestations include acute infection-induced encephalitis and pneumonitis. The susceptibility to encephalitis or pneumonitis appears to result from impaired TLR3-dependent interferon production by nonhematopoietic cells that reside within the central nervous system or lung epithelial cells. IMD83 transmission pattern is consistent with autosomal dominant or autosomal recessive inheritance with incomplete penetrance.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
5.1 TPM
Vagina
4.1 TPM
Adipose Visceral Omentum
4.1 TPM
Esôfago - Mucosa
4.0 TPM
Glândula adrenal
4.0 TPM
OUTRAS DOENÇAS (3)
herpes simplex encephalitissusceptibility to HIV infectionimmunodeficiency 83, susceptibility to viral infections
HGNC:11849UniProt:O15455
TRAF3TNF receptor-associated factor 3Major susceptibility factor inAltamente restrito
FUNÇÃO

Cytoplasmic E3 ubiquitin ligase that regulates various signaling pathways, such as the NF-kappa-B, mitogen-activated protein kinase (MAPK) and interferon regulatory factor (IRF) pathways, and thus controls a lot of biological processes in both immune and non-immune cell types (PubMed:33148796, PubMed:33608556). In TLR and RLR signaling pathways, acts as an E3 ubiquitin ligase promoting the synthesis of 'Lys-63'-linked polyubiquitin chains on several substrates such as ASC that lead to the activa

LOCALIZAÇÃO

CytoplasmEndosomeMitochondrion

VIAS BIOLÓGICAS (6)
Ovarian tumor domain proteasesNegative regulators of DDX58/IFIH1 signalingActivation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)TICAM1-dependent activation of IRF3/IRF7TNFR2 non-canonical NF-kB pathway
MECANISMO DE DOENÇA

Immunodeficiency 132A

An autosomal dominant immunologic disorder characterized by increased susceptibility to infection with certain pathogens, including Herpes simplex virus and Mycobacterium abscessus. Immunologic work-up shows impaired production of cytokines, including INFB and IL6.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
51.8 TPM
Cérebro - Hemisfério cerebelar
18.3 TPM
Cerebelo
18.0 TPM
Testículo
16.5 TPM
Pituitária
16.3 TPM
OUTRAS DOENÇAS (3)
herpes simplex encephalitis, susceptibility to, 3immunodeficiency 132bherpes simplex encephalitis
HGNC:12033UniProt:Q13114

Medicamentos aprovados (FDA)

1 medicamento encontrado nos registros da FDA americana.

💊 Ciclopirox (CICLOPIROX)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

329 variantes patogênicas registradas no ClinVar.

🧬 TRAF3: GRCh37/hg19 14q32.2-32.33(chr14:97521552-107285437)x3 ()
🧬 TRAF3: GRCh37/hg19 14q32.2-32.33(chr14:101180490-106329074)x1 ()
🧬 TRAF3: NM_145725.3(TRAF3):c.724C>T (p.Gln242Ter) ()
🧬 TRAF3: NM_145725.3(TRAF3):c.298-83A>T ()
🧬 TRAF3: NM_145725.3(TRAF3):c.245+1G>T ()
Ver todas no ClinVar

Vias biológicas (Reactome)

39 vias biológicas associadas aos genes desta condição.

Caspase activation via Death Receptors in the presence of ligand MyD88-independent TLR4 cascade Toll Like Receptor 3 (TLR3) Cascade TICAM1, RIP1-mediated IKK complex recruitment RIP-mediated NFkB activation via ZBP1 TRIF-mediated programmed cell death TICAM1 deficiency - HSE TRAF3 deficiency - HSE TLR3-mediated TICAM1-dependent programmed cell death TICAM1-dependent activation of IRF3/IRF7 TICAM1,TRAF6-dependent induction of TAK1 complex Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) IKK complex recruitment mediated by RIP1 TRAF6-mediated induction of TAK1 complex within TLR4 complex IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation Trafficking and processing of endosomal TLR UNC93B1 deficiency - HSE IRF3 mediated activation of type 1 IFN DDX58/IFIH1-mediated induction of interferon-alpha/beta Regulation of innate immune responses to cytosolic DNA STAT6-mediated induction of chemokines IRF3-mediated induction of type I IFN PINK1-PRKN Mediated Mitophagy TNFR1-induced proapoptotic signaling Regulation of TNFR1 signaling Interleukin-37 signaling TRAF3-dependent IRF activation pathway TRAF6 mediated IRF7 activation Negative regulators of DDX58/IFIH1 signaling Potential therapeutics for SARS SARS-CoV-1 activates/modulates innate immune responses SARS-CoV-2 activates/modulates innate and adaptive immune responses TLR3 deficiency - HSE RSV-host interactions TNFR2 non-canonical NF-kB pathway TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway Ovarian tumor domain proteases

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Encefalite por vírus herpes simplex

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

5 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
217 papers (10 anos)
#1

Severe herpes simplex virus encephalitis complicated by atypical Takotsubo cardiomyopathy with left ventricular systolic dysfunction.

BMJ case reports2026 Feb 19

A previously healthy woman in her 30s presented with high-grade fever, photophobia and fluctuating consciousness, and was diagnosed with herpes simplex virus type 1\ encephalitis. Her condition deteriorated, requiring intensive care support for type 1 respiratory failure. During her intensive care unit stay, she was found to have significant left ventricular systolic dysfunction with basal-mid akinesia and apical sparing on echocardiography. Cardiac MRI demonstrated features consistent with stress-induced (Takotsubo) cardiomyopathy. She made a complete neurological and cardiac recovery with supportive care, antiviral therapy and temporary heart-failure therapy. This case highlights the importance of considering cardiac involvement in severe encephalitis and the multidisciplinary management required for rare neuro-cardiac interactions.

#2

Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial.

The Lancet. Neurology2026 Feb

Herpes simplex virus (HSV) encephalitis is characterised by inflammation and swelling of the brain, resulting in death or severe neurocognitive sequelae. HSV encephalitis is treated with the antiviral aciclovir but still has substantial mortality and morbidity. Adjunct corticosteroids are sometimes used, but whether they improve the outcome is unclear. We aimed to establish the safety and efficacy of adjunct corticosteroids in HSV encephalitis. In this multicentre, observer-blind, randomised, phase 3 trial, adults with HSV encephalitis admitted to 53 hospitals in the UK were randomly assigned to receive intravenous dexamethasone (10 mg/kg, four times daily for 4 days) plus intravenous aciclovir (10 mg/kg three times daily for at least 14 days; dexamethasone group), or intravenous aciclovir alone (control group). Eligible patients aged 16 years or older had suspected encephalitis (a febrile illness with new onset seizure, new focal neurological signs or alteration in consciousness, cognition, personality, or behaviour), with positive HSV type 1 or type 2 PCR test in CSF. Participants were randomly assigned by the trial team at the recruiting site, using a secure web-based randomisation programme. The primary outcome was verbal memory score at 26 weeks, measured by the Wechsler Memory Scale (WMS)-IV auditory memory index. Analyses of primary and secondary outcomes were performed according to the modified intention-to-treat principle, and safety analyses were based on whether participants received at least one dose of the study drug. Trial neuropsychologists assessing the primary outcome, and statisticians involved in the study's primary outcome, were masked to treatment group allocation. The trial is registered with the International Standard Randomised Controlled Trial Number Registry, ISRCTN11774734, and EudraCT, EudraCT2016-004835-19, and is completed. Between Sept 22, 2016, and Feb 2, 2022, 94 patients with HSV encephalitis were recruited, 47 (20 [43%] female and 27 [57%] male) to the dexamethasone group, and 47 (24 [51%] female and 23 [49%] male) to the control group. Dexamethasone was initiated a median 7 (IQR 4-8) days after hospital admission. Seven patients withdrew consent, and six were lost to follow-up. Thus, 81 were included in the modified intention-to-treat analysis (39 in the treatment group and 42 in the control group). The primary outcome, verbal memory score at 26 weeks, did not differ significantly between the groups (71 [SD 26] in the dexamethasone group, and 69 [SD 25] in the control group; adjusted difference 1·77 [95% CI -9·57 to 13·12; p=0·76). There were 27 adverse events involving 18 (38%) participants in the control group, and 25 adverse events involving 18 (40%) participants in the dexamethasone group. The most common serious adverse events were seizures requiring readmission to hospital (affecting one [2%] patient in the dexamethasone group and one [2%] patient in the control group) and thrombotic events, including deep vein thrombosis (affecting one [2%] patient in the dexamethasone group) and pulmonary embolism (affecting one [2%]patient in the dexamethasone group). There were no treatment-related deaths. In adults with HSV encephalitis, dexamethasone plus aciclovir had a satisfactory safety profile but did not improve verbal memory score compared with aciclovir alone. Given the established role of corticosteroids in other inflammatory encephalitides, our findings suggest that their early use in suspected encephalitis is unlikely to be harmful. Future studies should assess more targeted immunomodulatory approaches in HSV encephalitis. National Institute for Health and Care Research.

#3

Effect of different doses of dexamethasone on the penetration of acyclovir across the blood-brain barrier.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences2026 Jan 01

Acyclovir (ACV) is a widely used antiviral agent for the treatment of herpes simplex virus encephalitis. Dexamethasone (DEX) is often co-administered as an adjunctive therapy. Tariquidar (TQD), a potent and selective inhibitor of P-glycoprotein, has been demonstrated to enhance the brain accumulation of ACV. This study is designed to systematically investigate the impact of varying DEX dosages on the blood-brain barrier (BBB) transport of ACV, elucidate the mechanisms involved, and evaluate the therapeutic potential of TQD in the management of herpes simplex virus encephalitis. Microdialysis, coupled with high-performance liquid chromatography, was employed to measure unbound ACV concentrations in blood and brain tissue at pre-determined time intervals. The effects of low (0.5 mg/kg), moderate (1 mg/kg), and high (3 mg/kg) doses of DEX, administered continuously for 4 days, on the pharmacokinetic parameters of ACV were evaluated in the presence and absence of tariquidar (TQD, P-glycoprotein inhibitor, 8 mg/kg). The BBB transport of ACV was assessed by calculating the ratio of the area under the unbound brain drug concentration-time curve to the area under the unbound blood drug concentration over time, to reflect changes in the BBB transport (Kp,uu,brain) of ACV. The mean of the area under the unbound brain and blood drug concentration-time curve, and Kp,uu,brain in rats of the solvent control (SC) group were 2674 ± 448 min·μg/mL, 564 ± 136 min·μg/mL, and 20.9 %, respectively. In the low-dose DEX group, ​​the Kp,uu,brain​ of ACV was 19.5 %, with no statistically significant difference compared with the SC group (P > 0.05). In the moderate- and high-dose DEX groups, the Kp,uu,brain​ of ACV decreased to 17.0 % and 14.0 %, respectively, with a statistically significant difference compared with the SC group (P < 0.001). Pairwise comparisons further revealed significant differences in the Kp,uu,brain of ACV among different DEX dose groups. Conversely, TQD administration increased the Kp,uu,brain of ACV by 1.40-fold (P < 0.001). The Kp,uu,brain in the TQD plus low-dose DEX group was 27.1 %, significantly higher than that of the SC group (P < 0.001). The Kp,uu,brain of the TQD plus moderate-dose DEX and TQD plus high-dose DEX groups was 21.6 % and 18.4 %, respectively, with no significant difference compared to the SC group (P > 0.05). Low-dose DEX does not significantly alter the BBB transport of ACV. However, moderate to high doses of DEX exhibit a dose-dependent reduction in ACV penetration across the BBB. Co-administration of TQD with DEX counteracts this effect, and even enhancing the BBB transport of ACV.

#4

Dexamethasone in herpes simplex virus encephalitis: timely insights amid study limitations.

The Lancet. Neurology2026 Feb
#5

Herpes Simplex Virus Encephalitis With Cerebellar Infarction and Cortical Laminar Necrosis.

Cureus2026 Feb

Herpes simplex virus (HSV) encephalitis typically involves the temporal lobes, and cerebellar involvement with stroke and cortical laminar necrosis (CLN) is rare. A 40-year-old man with no prior comorbidities presented with 10 days of positional vertigo, vomiting and intermittent fever. Initial otorhinolaryngology assessment showed bilateral nystagmus and a positive fistula test, and he was treated as having a peripheral vestibular disorder. He re-presented with persistent vertigo and new confusion; on admission, he was febrile, hypertensive and ataxic, and within 24 hours, he developed worsening encephalopathy, focal deficits and generalised tonic-clonic seizures. Cerebrospinal fluid (CSF) analysis demonstrated lymphocytic pleocytosis, elevated protein, normal glucose, raised opening pressure and red blood cells, and polymerase chain reaction (PCR) for HSV DNA was positive, confirming HSV encephalitis. Brain magnetic resonance imaging (MRI) revealed an acute infarction in the right greater than the left cerebellar hemisphere with corresponding diffusion restriction on diffusion-weighted and apparent diffusion coefficient sequences. Follow-up imaging in the subacute phase showed curvilinear T1 hyperintensities along the cerebellar cortical ribbon consistent with CLN. The patient was treated with intravenous acyclovir, high-dose corticosteroids, antiepileptic drugs, osmotherapy, blood pressure control and supportive care. Over a three-week admission, his sensorium normalised, and seizures ceased, but truncal and appendicular ataxia persisted. At early outpatient review, he was ambulant with a cane, with mild residual truncal ataxia and no further seizures. This case highlights that HSV encephalitis can present with an acute vestibulocerebellar syndrome and be complicated by cerebellar infarction and CLN and emphasises the need for early neuroimaging and lumbar puncture in febrile patients with 'peripheral' vertigo.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC362 artigos no totalmostrando 199

2026

Herpes Simplex Virus Encephalitis With Cerebellar Infarction and Cortical Laminar Necrosis.

Cureus
2026

Severe herpes simplex virus encephalitis complicated by atypical Takotsubo cardiomyopathy with left ventricular systolic dysfunction.

BMJ case reports
2025

Voxel-based morphometry and functional connectivity changes are associated with cognitive function in herpes simplex virus encephalitis.

Frontiers in neuroscience
2026

Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial.

The Lancet. Neurology
2026

Dexamethasone in herpes simplex virus encephalitis: timely insights amid study limitations.

The Lancet. Neurology
2025

Epidemiology and Prognostic Factors of Herpes Simplex Virus Encephalitis in Japan: A Nationwide Database Study.

Journal of epidemiology
2026

Rhoifolin prevents herpes simplex virus encephalitis by modulating SESN2 to regulate the Keap1/Nrf2 and AMPK/Nox pathways to inhibit neuro-oxidative damage in mice.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2025

Herpes Simplex Virus Type 1 Encephalitis in a Six-Year-Old Girl: A Case Report From Latin America.

Cureus
2025

Anti-NMDA receptor encephalitis following Murray Valley encephalitis: a case report.

ASM case reports
2026

Effect of different doses of dexamethasone on the penetration of acyclovir across the blood-brain barrier.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
2025

Study on the final diagnosis of nervous system diseases with psychiatric symptoms as manifestation onset.

BMC psychiatry
2025

When Neurology Overlaps: Herpes Simplex Virus Encephalitis in a Patient with Progressive Multiple Sclerosis.

Cureus
2026

Genetically heterozygous - transcriptionally homozygous IRF7 deficiency underlies herpesvirus CNS infections in humans.

The Journal of experimental medicine
2025

Exploring the psychiatric spectrum of herpes simplex virus encephalitis.

Indian journal of psychiatry
2025

Chronic granulomatous herpes simplex encephalitis in a child with digeorge syndrome- expanding the spectrum of herpes-associated neurological disease.

BMC infectious diseases
2025

Saving Vision in a Child With Light Perception Vision Due to Acute Retinal Necrosis Secondary to Herpes Simplex Virus Encephalitis.

Journal of pediatric ophthalmology and strabismus
2025

Health economic impact of early versus delayed treatment of herpes simplex virus encephalitis in the UK.

BMJ open
2025

Unraveling Herpes Simplex Virus Encephalitis: Diagnosis and Management.

Annals of African medicine
2025

Diagnostic Value of the "Insular Knife-Cut" Sign in Patients With Suspected Herpes Simplex Virus Encephalitis.

European journal of neurology
2025

Clinical phenotype and outcomes in autoimmune encephalitis after herpes simplex virus encephalitis: A systematic review and meta-analysis.

The Journal of infection
2025

Association between early initiation of anti-herpesvirus therapy and outcomes in herpesvirus encephalitis: A Nationwide Retrospective Propensity Score Analysis in Japan.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2025

Limited efficacy of adjunctive therapy in a case of severe herpes simplex virus encephalitis: A case report and literature review.

IDCases
2025

Outcome of herpes simplex virus encephalitis in children and young people.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2025

Viral encephalitis - update on pathogenesis and treatment.

Current opinion in neurology
2025

Neurological outcomes and disability predictors in paediatric herpes simplex virus encephalitis: a multicentre cohort from French tertiary hospitals.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2025

[Risk factors and prognosis of anti-N-methyl-D-aspartate receptor encephalitis following herpes simplex virus encephalitis in children].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Performance of cryptogenic new onset refractory status epilepticus score in a Brazilian cohort after testing for antineuronal antibodies with tissue-based and cell-based assays.

Epilepsia
2025

A child who suffered from HSV encephalitis and AE with positive anti-MOG results: a case report.

Brain injury
2025

Lessons From the Edge of Reactivation: Managing Herpes Simplex Virus Encephalitis Years After Initial Infection in High-Risk Neurosurgical Patients.

Cureus
2024

Navigating herpes simplex encephalitis: Family medicine perspectives from Jharkhand, India.

Journal of family medicine and primary care
2024

Herpes Simplex Virus Encephalitis in a Post-operative Case of Follicular Thyroid Carcinoma.

Discoveries (Craiova, Romania)
2025

Epilepsy surgery for postinfectious lesions: A review.

Epilepsy &amp; behavior : E&amp;B
2024

When the Mind Fails: A Mysterious Case of Concurrent Neurosyphilis, Herpes Simplex Virus Encephalitis, and Suspected Autoimmune Encephalitis.

Cureus
2024

A Rare Presentation of Herpes Simplex Virus Encephalitis With Ischemic Stroke and Associated Acyclovir-Induced Acute Kidney Injury.

Cureus
2024

Sinus node dysfunction preceding herpes simplex encephalitis: A case report.

Journal of cardiology cases
2024

MOG encephalitis secondary to herpes simplex virus encephalitis: A case report.

Asian journal of surgery
2024

An uncommon combination: a case report of herpes simplex virus encephalitis induced takotsubo cardiomyopathy.

AME case reports
2024

A Diagnostically Challenging Case of Recurrent Encephalitis With Impending Herniation.

Cureus
2024

Using Multiphoton Intravital Microscopy to Study Neutrophil Transmigration and Blood-Brain Barrier Permeability in a Mouse Model of Herpes Simplex Virus Encephalitis.

Methods in molecular biology (Clifton, N.J.)
2024

Specific clinical and radiological characteristics of anti-NMDA receptor autoimmune encephalitis following herpes encephalitis.

Journal of neurology
2024

Predictors of Neurologic Disability at Hospital Discharge for Acyclovir-treated Pediatric Herpes Simplex Virus Encephalitis.

The Pediatric infectious disease journal
2024

Insights into adjunctive corticosteroid therapy in fulminant herpes simplex virus encephalitis: case analysis with contrasting outcomes.

Encephalitis (Seoul, Korea)
2024

A rare case of herpes simplex virus encephalitis from viral reactivation following surgically treated traumatic brain injury.

Brain injury
2024

Bilateral Acute Retinal Necrosis Secondary to Herpes Simplex Virus Encephalitis After Craniotomy for Tuberculum Meningioma Resection.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2024

A Neurosyphilis Case Mimicking Herpes Simplex Virus Encephalitis in an African American Male.

Cureus
2024

Herpes Simplex Virus Encephalitis in Patients With Autoimmune Conditions or Exposure to Immunomodulatory Medications.

Neurology
2024

Characteristics, management and outcome of Herpes Simplex and Varicella-Zoster virus encephalitis: a multicentre prospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
2024

Movement disorders associated with pediatric encephalitis.

Handbook of clinical neurology
2024

Neonatal herpes simplex virus encephalitis with intracranial bleeding in a newborn baby with concurrent rhesus incompatibility.

BMJ case reports
2023

Case report: Overlapping anti-AMPAR encephalitis with anti-IgLON5 disease post herpes simplex virus encephalitis.

Frontiers in immunology
2024

The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity.

Brain : a journal of neurology
2023

Paraneoplastic Neurologic Syndromes.

Continuum (Minneapolis, Minn.)
2023

Vertigo Can Give Notice of Herpes Simplex Virus Encephalitis.

Advanced biomedical research
2023

Chronic Herpes Simplex Virus Encephalitis with Unexpected Neuropathological Findings.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2023

Changing Clinical Profile and Predictors of Mortality in Patients of Acute Febrile Encephalopathy from North India.

Journal of global infectious diseases
2024

Review of the therapeutic potential of Forsythiae Fructus on the central nervous system: Active ingredients and mechanisms of action.

Journal of ethnopharmacology
2023

Herpes Simplex Virus Encephalitis after Recovery from Coronavirus Disease 2019: A Rare Case Report.

Internal medicine (Tokyo, Japan)
2023

Anti-NMDAR encephalitis secondary to acute necrotizing encephalopathy caused by herpes simplex virus infection in infants: Case series.

Clinical neurology and neurosurgery
2023

Post-herpes simplex virus encephalitis autoimmunity: more the rule than the exception.

Brain : a journal of neurology
2023

Luteolin inhibits herpes simplex virus 1 infection by activating cyclic guanosine monophosphate-adenosine monophosphate synthase-mediated antiviral innate immunity.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2023

The Worldwide Prevalence of Herpes Simplex Virus Encephalitis and Meningitis: A Systematic Review and Meta-Analysis.

Turkish archives of pediatrics
2023

Understanding Herpes Simplex Virus Type 1 Versus Herpes Simplex Virus Type 2 Encephalitis After Neurosurgery: A Case Series and Literature Review.

Surgical infections
2023

The importance of ruling out herpes simplex virus encephalitis in N-methyl-ᴅ-aspartate receptor encephalitis studies.

Encephalitis (Seoul, Korea)
2023

AKI in a Patient Treated for Herpes Simplex Virus Encephalitis.

Kidney360
2023

Herpes Simplex Virus Encephalitis.

Clinical journal of oncology nursing
2023

Association between human genetic variants affecting the host NK cell response and the development of herpes simplex virus type 1 encephalitis.

Journal of medical virology
2023

Temporal lobe hemorrhage as a complication of HSV encephalitis: a case report.

Clinical case reports
2022

MRI changes and expressions of neuron-specific enolase and monocyte chemoattractant protein-1 in cerebrospinal fluid in patients with severe herpes simplex virus encephalitis.

Cellular and molecular biology (Noisy-le-Grand, France)
2023

Post Herpetic Anti-NMDA- Receptor Encephalitis in an 18-month-old Infant.

Iranian journal of child neurology
2023

Modulation of virus-induced neuroinflammation by the autophagy receptor SHISA9 in mice.

Nature microbiology
2023

Herpes simplex virus encephalitis: An atypical presentation of delirium.

Clinical case reports
2023

Retrospective Pediatric Cohort Study Validates NEOS Score and Demonstrates Applicability in Children With Anti-NMDAR Encephalitis.

Neurology(R) neuroimmunology &amp; neuroinflammation
2023

Herpes simplex virus encephalitis mimicking acute ischemic stroke.

Surgical neurology international
2023

Recurrent herpes simplex virus encephalitis with presumptive Human Herpesvirus 6 chromosomal integration.

IDCases
2023

The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation.

Journal of neuroinflammation
2023

When herpes simplex virus encephalitis meets antiviral innate immunity.

Frontiers in immunology
2022

Herpes Simplex Virus Encephalitis: An Unexpected Outcome in a Polytrauma Patient.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
2022

Increased volume of cerebral oedema is associated with risk of acute seizure activity and adverse neurological outcomes in encephalitis - regional and volumetric analysis in a multi-centre cohort.

BMC neurology
2022

Case report: Tongdu Xingshen acupuncture for a patient with persistent vegetative state after herpes simplex virus encephalitis.

Frontiers in neurology
2022

Herpes simplex virus encephalitis in atopic dermatitis patients and responses to dupilumab: A real association or a chance occurrence?

Pediatric dermatology
2022

[Protective effect of Forsythiae Fructus extract on mice with herpes simplex encephalitis].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
2022

Herpes Simplex Virus 1 Induces Microglia Gasdermin D-Dependent Pyroptosis Through Activating the NLR Family Pyrin Domain Containing 3 Inflammasome.

Frontiers in microbiology
2022

A rare presentation of herpes simplex virus encephalitis occurring in a pediatric patient on dupilumab for atopic dermatitis.

Pediatric dermatology
2022

Post-COVID-19 HSV encephalitis: a review.

QJM : monthly journal of the Association of Physicians
2022

Herpes Simplex Virus Encephalitis With Initial Negative Polymerase Chain Reaction in the Cerebrospinal Fluid: Prevalence, Associated Factors, and Clinical Impact.

Critical care medicine
2021

Stress Cardiomyopathy Triggered by Status Epilepticus Secondary to Herpes Simplex Virus Encephalitis: Case Report and Literature Review.

Cureus
2021

Clinical Characteristics and Follow-Up of Seizures in Children With Anti-NMDAR Encephalitis.

Frontiers in neurology
2022

Life-Threatening Enterovirus 71 Encephalitis in Unrelated Children with Autosomal Dominant TLR3 Deficiency.

Journal of clinical immunology
2021

Varicella-zoster virus encephalitis resembling herpes simplex virus encephalitis.

BMJ case reports
2022

Epileptic negative myoclonus in herpes simplex virus encephalitis.

Epileptic disorders : international epilepsy journal with videotape
2021

Quercus acuta Thunb. (Fagaceae) and Its Component, Isoquercitrin, Inhibit HSV-1 Replication by Suppressing Virus-Induced ROS Production and NF-κB Activation.

Antioxidants (Basel, Switzerland)
2022

Human viral encephalitis associated with suid herpesvirus 1.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

The use of antiviral drugs in children.

Journal of chemotherapy (Florence, Italy)
2021

Herpes Simplex Virus-2 Encephalitis Complicated with Multiple Cranial Neuritis and Dysautonomia.

Journal of pediatric neurosciences
2021

Non-convulsive status epilepticus as an initial manifestation of herpes simplex virus encephalitis.

Epileptic disorders : international epilepsy journal with videotape
2021

A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis.

Scientific reports
2022

Atypical imaging presentation of herpes simplex virus encephalitis in paediatric immunocompromised oncology patients.

Journal of medical imaging and radiation oncology
2022

Deep Learning-Enabled Identification of Autoimmune Encephalitis on 3D Multi-Sequence MRI.

Journal of magnetic resonance imaging : JMRI
2021

Anti-inflammatory effects of kaempferol-3-O-rhamnoside on HSV-1 encephalitis in vivo and in vitro.

Neuroscience letters
2021

Long-term sequelae of herpes simplex virus encephalitis-related white matter injury: correlation of neuropsychological outcome and diffusion tensor imaging.

Journal of neurovirology
2021

Anti-NMDAR Encephalitis After Neonatal HSV-1 Infection in a Child With Low TLR-3 Function.

Pediatrics
2022

Analysing triggers for anti-NMDA-receptor encephalitis including herpes simplex virus encephalitis and ovarian teratoma: results from the Queensland Autoimmune Encephalitis cohort.

Internal medicine journal
2021

Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management.

Frontiers in neurology
2021

Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitis.

BMJ open
2022

US Hospitalizations and 60-Day Readmission Rates Associated With Herpes Simplex Virus Encephalitis: Analysis of All Cause Readmissions and Encephalopathy Associated Readmissions.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2021

Pediatric Autoimmune Encephalitis and Its Relationship With Infection.

Pediatric neurology
2021

Anti-N-Methyl-D-Aspartate receptor Encephalitis as a potential cause of worsening Herpes Simplex Virus Encephalitis.

JPMA. The Journal of the Pakistan Medical Association
2021

Untreated herpes simplex virus encephalitis without a fatal outcome.

Journal of neurovirology
2021

ASC-dependent inflammasomes contribute to immunopathology and mortality in herpes simplex encephalitis.

PLoS pathogens
2021

Child Neurology: Intractable Epilepsy and Transient Deficits in a Patient With a History of Herpes Simplex Virus Encephalitis.

Neurology
2021

Fever with no elevation in inflammatory markers: herpes simplex virus encephalitis.

QJM : monthly journal of the Association of Physicians
2020

An adolescent with herpes simplex encephalitis, presenting with mild symptoms and rapid deterioration: A case report.

SAGE open medical case reports
2020

Epilepsy after brain infection in adults: A register-based population-wide study.

Neurology
2020

An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.

Journal of virology
2020

Management and results of epilepsy surgery associated with acyclovir prophylaxis in four pediatric patients with drug-resistant epilepsy due to herpetic encephalitis and review of the literature.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2020

Feasibility of Continuous Infusions of Acyclovir.

The Pediatric infectious disease journal
2020

Herpes simplex virus encephalitis after temporal lobe resection: an infrequent but treatable complication of epilepsy surgery.

European journal of neurology
2020

Long-Term Survival, Morbidity, Social Functioning and Risk of Disability in Patients with a Herpes Simplex Virus Type 1 or Type 2 Central Nervous System Infection, Denmark, 2000-2016.

Clinical epidemiology
2020

Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors.

Therapeutic advances in neurological disorders
2021

Intraventricular hemorrhage as clinical presentation of herpes simplex virus encephalitis. A case report and review of the literature.

The International journal of neuroscience
2020

[A case of herpes simplex virus encephalitis recurring after a seven-year interval].

Rinsho shinkeigaku = Clinical neurology
2020

Anti-NMDAR Encephalitis Following Herpes Simplex Virus Encephalitis: 2 Cases From Portugal.

The Neurohospitalist
2020

The PET Sandwich: Using Serial FDG-PET Scans with Interval Burst Suppression to Assess Ictal Components of Disease.

Neurocritical care
2020

Cerebral HSV-1 Vasculitis as a Fatal Complication of Immunosuppression in Non-Hodgkin´s Lymphoma: A Case Report and Review of the Literature.

Pathogens (Basel, Switzerland)
2021

Opsoclonus-myoclonus syndrome associated with herpes simplex virus infection: a case report.

The International journal of neuroscience
2020

Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis.

Clinical microbiology reviews
2020

Herpes simplex virus encephalitis of childhood: inborn errors of central nervous system cell-intrinsic immunity.

Human genetics
2019

Differential Diagnosis of Autoimmune Encephalitis from Infectious Lymphocytic Encephalitis by Analysing the Lymphocyte Subsets of Cerebrospinal Fluid.

Analytical cellular pathology (Amsterdam)
2020

Brucellosis mimicking herpes simplex virus encephalitis.

The Lancet. Infectious diseases
2019

Herpes simplex encephalitis in adult patients with MASP-2 deficiency.

PLoS pathogens
2019

Herpes Simplex Virus Encephalitis: Patterns of Epidemiology and Outcomes of Patients Admitted to the Intensive Care Unit in Texas, 2008 - 2016.

Journal of clinical medicine research
2019

An unusual cause of bowel ischemia in an intensive care unit patient with herpes simplex virus encephalitis.

Journal of surgical case reports
2019

The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trial.

Neurological research and practice
2019

Rapid detection of human herpes virus by next-generation sequencing in a patient with encephalitis.

Virology journal
2019

Herpes simplex virus encephalitis in a patient receiving ustekinumab associated with extensive cerebral oedema and brainshift successfully treated by immunosuppression with dexamethasone.

BMJ case reports
2019

The role of infections in autoimmune encephalitides.

Revue neurologique
2020

Recurrent Herpes Zoster Ophthalmicus in a Patient With a Novel Toll-Like Receptor 3 Variant Linked to Compromised Activation Capacity in Fibroblasts.

The Journal of infectious diseases
2019

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Following Herpes Simplex Virus Encephalitis in a Pediatric Patient.

Pediatric neurology
2019

Acute hemorrhagic leukoencephalitis of Weston Hurst secondary to herpes encephalitis presenting as status epilepticus: A case report and review of literature.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2019

Herpes Simplex Virus 1 encephalitis with normal cerebrospinal fluid after brain radiotherapy in a patient with glioblastoma. A case report and review of literature.

Acta bio-medica : Atenei Parmensis
2019

HSV-Encephalitis Reactivation after Cervical Spine Surgery.

Case reports in surgery
2019

Late-onset Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes Presenting With Auditory Agnosia.

The neurologist
2019

Herpes simplex virus encephalitis update.

Current opinion in infectious diseases
2019

Continuous Electroencephalogram as a Biomarker of Disease Progression and Severity in Herpes Simplex Virus-1 Encephalitis.

Clinical EEG and neuroscience
2019

Diagnosis and Management of Autoimmune Dementia.

Current treatment options in neurology
2019

Cerebral Venous Thrombosis as Rare Presentation of Herpes Simplex Virus Encephalitis.

Case reports in infectious diseases
2019

The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data.

The lancet. Psychiatry
2019

The recruitment of peripheral blood leukocytes to the brain is delayed in susceptible BALB/c compared to resistant C57BL/6 mice during herpes simplex virus encephalitis.

Journal of neurovirology
2019

Cerebrovascular manifestations of herpes simplex virus infection of the central nervous system: a systematic review.

Journal of neuroinflammation
2019

Recurrent Herpes Simplex Virus Encephalitis After Epilepsy Surgery.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2018

[A 64-year-old male with recurrence of herpes simplex encephalitis after suffering from severe pneumonia and sepsis].

Rinsho shinkeigaku = Clinical neurology
2018

Long-term outcome of acute central nervous system infection in children.

Pediatric investigation
2018

The clinical approach to managing herpes simplex virus encephalitis.

British journal of hospital medicine (London, England : 2005)
2018

Herpes simplex virus encephalitis temporally associated with dimethyl fumarate-induced lymphopenia in a multiple sclerosis patient.

Multiple sclerosis and related disorders
2018

Comparing molecular quantification of herpes simplex virus (HSV) in cerebrospinal fluid (CSF) with quantitative structural and functional disease severity in patients with HSV encephalitis (HSVE): Implications for improved therapeutic approaches.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
2018

Both IRF3 and especially IRF7 play a key role to orchestrate an effective cerebral inflammatory response in a mouse model of herpes simplex virus encephalitis.

Journal of neurovirology
2018

Insular cortex lesion and autonomic instability in a herpes simplex virus encephalitis patient.

Journal of neurovirology
2018

Real-time Utilization of Metagenomic Sequencing in the Diagnosis and Treatment Monitoring of an Invasive Adenovirus B55 Infection and Subsequent Herpes Simplex Virus Encephalitis in an Immunocompetent Young Adult.

Open forum infectious diseases
2018

Multimodal management of severe herpes simplex virus encephalitis: A case report and literature review.

Neuro-Chirurgie
2018

Autoimmune Encephalitis Following Herpes Simplex Virus Encephalitis in an Infant.

Indian pediatrics
2018

Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong.

Brain &amp; development
2018

Herpes Simplex Virus Encephalitis: Atypical Presentation as a Right Middle Cerebral Artery Stroke.

Cureus
2018

Semantic language deficit developing following herpes simplex encephalitis: reorganization "cannibalising" language centers?

Neurocase
2018

Cytokine/chemokine elevation during the transition phase from HSV encephalitis to autoimmune anti-NMDA receptor encephalitis.

Brain &amp; development
2018

Premature Termination of Treatment in Neonatal Herpes Simplex Virus Encephalitis.

Pediatric neurology
2018

A Case of Bell's Palsy Complicated by Subsequent Herpes Simplex Virus Encephalitis.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2017

Care beyond the hospital ward: understanding the socio-medical trajectory of herpes simplex virus encephalitis.

BMC health services research
2018

Use of high b value diffusion-weighted magnetic resonance imaging in acute encephalopathy/encephalitis during childhood.

Brain &amp; development
2018

Herpes simplex encephalitis with thalamic, brainstem and cerebellar involvement.

The neuroradiology journal
2017

Burden of herpes simplex virus encephalitis in the United States.

Journal of neurology
2017

Extended Clinical Spectrum of Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Children: A Case Series.

Pediatric neurology
2017

Epilepsy surgery for epileptic encephalopathy as a sequela of herpes simplex encephalitis: case report.

Journal of neurosurgery. Pediatrics
2017

Cerebrospinal fluid cyto-/chemokine profile during acute herpes simplex virus induced anti-N-methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae.

Developmental medicine and child neurology
2017

TLR3 Mutations in Adult Patients With Herpes Simplex Virus and Varicella-Zoster Virus Encephalitis.

The Journal of infectious diseases
2017

Postviral autoimmune encephalitis: manifestations in children and adults.

Current opinion in neurology
2017

NMDAR Encephalitis Following Herpes Simplex Virus Encephalitis.

Current infectious disease reports
2016

Extratemporal herpes encephalitis during natalizumab treatment: A case report.

Multiple sclerosis and related disorders
2017

Protective role of CX3CR1 signalling in resident cells of the central nervous system during experimental herpes simplex virus encephalitis.

The Journal of general virology
2017

Anti-N-methyl-D-aspartate receptor encephalitis after Herpes simplex virus-associated encephalitis: an emerging disease with diagnosis and therapeutic challenges.

Infection
2017

Differences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitis.

Acta neuropathologica
2016

Improved CT Detection of Acute Herpes Simplex Virus Type 1 Encephalitis Based on a Frequency-Selective Nonlinear Blending: Comparison With MRI.

AJR. American journal of roentgenology
2016

Diagnosis and Treatment of Central Nervous System Infections in the Emergency Department.

Emergency medicine clinics of North America
2016

Poster 215 Gustatory Agnosia Following Herpes Simplex Virus Encephalitis: A Case Report.

PM &amp; R : the journal of injury, function, and rehabilitation
2017

Acute retinal necrosis results in low vision in a young patient with a history of herpes simplex virus encephalitis.

Clinical &amp; experimental optometry
2016

Herpes simplex encephalitis is linked with selective mitochondrial damage; a post-mortem and in vitro study.

Acta neuropathologica
2016

Non-paraneoplastic limbic encephalitis and central nervous HHV-6B reactivation: Causality or coincidence?

Neuropathology : official journal of the Japanese Society of Neuropathology
2016

Clinical outcomes in children with herpes simplex encephalitis receiving steroid therapy.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
2016

A study on viral CNS inflammation beyond herpes encephalitis.

Journal of neurovirology
2016

The Type I Interferon Response Determines Differences in Choroid Plexus Susceptibility between Newborns and Adults in Herpes Simplex Virus Encephalitis.

mBio
2016

[Cognitive Impairment in Patients with Bacterial Meningitis and Encephalitides].

Brain and nerve = Shinkei kenkyu no shinpo
2016

Elaboration of a clinical and paraclinical score to estimate the probability of herpes simplex virus encephalitis in patients with febrile, acute neurologic impairment.

European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology
2017

Absent anti-N-methyl-D-aspartate receptor NR1a antibodies in herpes simplex virus encephalitis and varicella zoster virus infections.

The International journal of neuroscience
2016

Recurrent Herpes Simplex Virus Encephalitis After Neurologic Surgery.

World neurosurgery
2015

HSV Encephalitis with Normal CSF - A Case Report with Review of Literature.

Journal of clinical and diagnostic research : JCDR
2016

Group B streptococcal meningitis in a previously healthy man.

BMJ case reports
2015

[Clinical characteristics, prognosis and genetic susceptibility of herpes simplex encephalitis in children].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2016

Herpes simplex virus encephalitis in Peru: a multicentre prospective study.

Epidemiology and infection
2015

Infiltration Pattern of Blood Monocytes into the Central Nervous System during Experimental Herpes Simplex Virus Encephalitis.

PloS one
2016

[Herpes simplex virus encephalitis during pregnancy: Maternal and neonatal outcomes].

Medicina clinica
Ver todos os 362 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Encefalite por vírus herpes simplex.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Encefalite por vírus herpes simplex

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Severe herpes simplex virus encephalitis complicated by atypical Takotsubo cardiomyopathy with left ventricular systolic dysfunction.
    BMJ case reports· 2026· PMID 41713882mais citado
  2. Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial.
    The Lancet. Neurology· 2026· PMID 41579900mais citado
  3. Effect of different doses of dexamethasone on the penetration of acyclovir across the blood-brain barrier.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences· 2026· PMID 41237865mais citado
  4. Dexamethasone in herpes simplex virus encephalitis: timely insights amid study limitations.
    The Lancet. Neurology· 2026· PMID 41579883mais citado
  5. Herpes Simplex Virus Encephalitis With Cerebellar Infarction and Cortical Laminar Necrosis.
    Cureus· 2026· PMID 41798532mais citado
  6. Neonatal herpes simplex virus encephalitis: a single-center retrospective study of 14 cases.
    Front Pediatr· 2026· PMID 41988145recente
  7. Neuroimaging features of incontinentia pigmenti: prompting genetic confirmation.
    BMJ Case Rep· 2026· PMID 41916690recente
  8. Voxel-based morphometry and functional connectivity changes are associated with cognitive function in herpes simplex virus encephalitis.
    Front Neurosci· 2025· PMID 41601536recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:1930(Orphanet)
  2. MONDO:0012521(MONDO)
  3. GARD:6649(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q19001292(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Encefalite por vírus herpes simplex
Compêndio · Raras BR

Encefalite por vírus herpes simplex

ORPHA:1930 · MONDO:0012521
Prevalência
Unknown
Herança
Multigenic/multifactorial, Not applicable
CID-10
B00.4+ · Infecções pelo vírus do herpes [herpes simples]
CID-11
Início
All ages
Prevalência
0.0 (Europe)
MedGen
UMLS
C0276226
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades